Science
Mechanism of Action
This substance, recognized as PCV21, functions as a vaccine by stimulating the body's immune system to produce antibodies against specific serotypes of Streptococcus pneumoniae bacteria. This action provides protection against severe infections like pneumonia and meningitis. There is no documented mechanism of action or efficacy related to topical application or direct skin benefits.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Key findings
- 01 Clinical trials for PCV21 vaccine (e.g., STRIDE-3, STRIDE-5, STRIDE-6) demonstrating immunogenicity and safety as a vaccine for preventing bacterial infections in adults.
Transparency
Dusting Analysis
PNA-21 CARBOXYETHYL FLUORENE is identified as an injectable vaccine and is not an ingredient typically used in topical cosmetic formulations. Therefore, the concept of 'dusting' in a skincare context is not applicable.
The Formula
Formulation
Stability
As PCV21 (CAPVAXIVE) vaccine, it is supplied in single-dose, prefilled syringes and requires refrigeration for optimal stability.
Conflicts
- Known severe allergic reaction (e.g., anaphylaxis) to any component of the PCV21 vaccine.
- Known severe allergic reaction to any diphtheria toxoid-containing vaccine (due to vaccine components).
Safety
Safety Profile
PNA-21 CARBOXYETHYL FLUORENE, as PCV21, was approved by the FDA in June 2024 for the prevention of invasive pneumococcal disease and pneumonia in adults aged ≥18 years via injection. Common solicited systemic adverse events observed in vaccine clinical trials included fatigue (27.1%), headache (18.4%), and myalgia (11.3%). Serious allergic reactions, including anaphylaxis, are a potential risk upon administration, and it is medically contraindicated for individuals with a history of severe allergic reactions to its components or diphtheria toxoid-containing vaccines. Safety for topical skincare application is unassessed.
Your Skin
Skin Compatibility
Our Assessment
Verdict
PNA-21 CARBOXYETHYL FLUORENE is unequivocally identified as PCV21, a medical vaccine, with no known or researched application, benefits, or safety profile for topical use in precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…